To broaden and validate our experimental data, we mined a GEO dataset obtained from hematopoietic progenitor cells (CD34+/CD38+) and hematopoietic stem cells (CD34+/CD38-), both derived from CML patients at diagnosis [42]. The gene discussed is CD38; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.